Spero Therapeutics (SPRO) Minority Interest (2016 - 2019)

Spero Therapeutics has reported Minority Interest for 4 years, with the latest figure at $355000.0 in Q3 2019.

• For the quarter ending Q3 2019, Minority Interest changed 0.0% year-over-year to $355000.0; the trailing twelve-month figure through Sep 2019 stood at $355000.0 (changed 0.0% YoY), and the FY2018 full-year result was $355000.0, changed 0.0% from the prior year.
• Minority Interest for Q3 2019 stood at $355000.0, roughly flat from $355000.0 in the prior quarter.
• The five-year high for Minority Interest was $6.4 million in Q2 2017, with the low at -$3.8 million in Q4 2016.
• Historically, Minority Interest has averaged $526636.4 across 4 years, with a median of $355000.0 in 2017.
• Annual changes were most pronounced in 2017 — Minority Interest soared 109.32% — and 2018, when it slumped 94.45%.
• Spero Therapeutics' Minority Interest stood at -$3.8 million in 2016, then jumped by 109.32% to $355000.0 in 2017, then changed by 0.0% to $355000.0 in 2018, then changed by 0.0% to $355000.0 in 2019.
• The last three Minority Interest figures came in at $355000.0 (Q3 2019), $355000.0 (Q2 2019), and $355000.0 (Q1 2019), per Business Quant data.